Optimising Pharmacist-led Medication Reviews in Primary Care

NCT05928104 | Completed

• 1 other identifier: IRAS 313644
• Study Type: observational
• Target: 15
• Locations: 1 country
• Sites: 3

Brief Summary

An increasing number of people are diagnosed with long-term conditions and are prescribed medicines to manage these conditions. Medication reviews (MRs) are used to optimise medicines, improve health outcomes, and decrease medicines related problems. Although medication reviews are widely used in health care settings, there has not been a dramatic change in the the rate at which patients experience poor medicines outcomes such as adverse drug reactions and hospitalisations. This research wants to understand how medication reviews by pharmacists are delivered in GP surgeries and community pharmacies. The research team plans to test a co-designed document, which outlines what pharmacists should do in a MR, in a small number of GP surgeries, on a limited number of patients. Pharmacists and patients who have used this document will be interviewed to understand their thoughts and feelings about the process.

Conditions

ALL, Adult

Outcome Measures

Primary Outcomes (2)

• Patient feasibility and acceptability

  Patients will be interviewed to assess their thoughts and feelings after receiving the medication review

  3 months

• Pharmacist feasibility and acceptability

  Pharmacists will be interviewed to assess their thoughts and feelings after delivering medication reviews using the service specification

  3 months

Interventions

Medication review OTHER

Pharmacist-led medication review in primary care using a co-designed document

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients will be recruited from the general practice sites that are recruited to participate in the study. These sites will be located in Norfolk, Suffolk and North East Essex

You may qualify if:

• Aged ≥ 18 years
• Due for a medication review by the practice pharmacist
• Effectively communicate in English
• Provide informed consent

You may not qualify if:

• Have no access to telephone/ internet
• Recently received a medication review

Sponsors & Collaborators

• University of East Anglia: lead

Study Sites (3)

Toftwood surgery

Dereham, Norflok, NR19 1LD, United Kingdom

Location

North Elmham surgery

Dereham, Norfolk, NR20 5JS, United Kingdom

Location

Sheringham Medical Practice

Sheringham, Norfolk, NR26 8RT, United Kingdom

Location

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

Medication Review

Condition Hierarchy (Ancestors)

Leukemia, Lymphoid; Leukemia; Neoplasms by Histologic Type; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases

Intervention Hierarchy (Ancestors)

Medication Systems; Organization and Administration; Health Services Administration; Patient Care Management

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 12, 2023
• First Posted: July 3, 2023
• Study Start: September 12, 2023
• Primary Completion: December 22, 2023
• Study Completion: January 31, 2024
• Last Updated: May 13, 2024

Record last verified: 2023-06

Data Sharing

• IPD Sharing: Will not share

Locations

GB (3)